Wan, M T <br/><br/>
Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal: ORIGINAL ARTICLE: Wolchok JD, Chiarion-Sileni V, Gonzalez R et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2017; 377:1345-56.  [electronic resource] 

 -  The British journal of dermatology  08 2018 
 - 296-300 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.16785  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Humans<br/>Ipilimumab<br/>Melanoma<br/>Nivolumab